http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100675403-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2561-113 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100675403-B1 |
| titleOfInvention | In Vitro Pregnancy Diabetes Methods and Measurement Kits |
| abstract | The present invention relates to a method for measuring gestational diabetes in vitro and a kit for measurement.n n n In vitro gestational diabetes measurement method of the present invention, 1) using genomic DNA isolated from pregnant women as a template primers and probes specific to each of the mitochondrial DNA (mtDNA) and endogenous reference DNA (endogenous reference DNA) Using a first step of performing real-time PCR; 2) a second step of determining an initial amount value and a threshold cycle value of each gene by measuring a signal by a probe for each real-time polymerase chain reaction cycle; 3) identifying a relative ratio of mtDNA to the intrinsic reference DNA of the pregnant woman from the values; And 4) comparing the ratio of the pregnant woman to be measured with the relative ratio of mtDNA to the intrinsic reference DNA of the normal pregnant woman.n n n The kit for measuring gestational diabetes of the present invention includes a primer set that can be used for polymerase chain reaction of mtDNA and 28S rRNA, and a marker for measuring each polymerase chain reaction product.n n n The method and measurement kit for gestational diabetes of the present invention can accurately and easily measure whether gestational diabetes, large-scale clinical research, screening and treatment of gestational diabetes treatment can be usefully applied to research and development. |
| priorityDate | 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.